(HealthDay News) — A new rule that aims to ensure the safety of infant formula has been finalized by the U.S. Food and Drug Administration. An initial version of the rule for manufacturers of infant formula was released in February and the final version contains some modifications and clarifications that were made in response to comments received by the FDA.
The agency said infant formula makers will have to start complying with the final rule by September 8. The rule requires manufacturers to prove that their infant formulas support normal physical growth and that the products be tested for nutrient content before they are sent to stores and at the end of their shelf life.
The rule also outlines good manufacturing practices specifically designed for infant formula, including mandatory testing for the disease-causing bacteria Salmonella and Cronobacter.
The new rule applies only to infant formulas meant for healthy infants who do not have unusual medical or dietary problems, the FDA said.